Training

SIB’s expertise has been invaluable to unlock the potential of our plant samples collection, which is being studied by our academic partners. Using the latest technology, SIB integrated information from various sources including taxonomy, mass spectrometry and biological results from 1600 plant extracts into a single, easy-to-use database, to support the search for drug candidates against tuberculosis and obesity.

Collaborating with SIB has been a clear positive for our laboratory. The OncoBench ® programme that we developed together has greatly simplified our workflows and increased our efficiency, while preserving the security of our patients’ personal data.

We pride ourselves on insisting on the highest standards of scientific rigour and the SIB proved to be an outstanding partner. Its leading expertise in bioinformatics and unique position as a not-for-profit organization made it an ideal partner for our first in-human clinical trial, which resulted in one of the highest-ranked publications to date in Nature Metabolism.

The combination of QCMD’s EQA expertise and global network with SIB’s bioinformatics know-how will help shape the quality assessment schemes in this rapidly developing area of molecular diagnostics.

The collaboration allowed us to make the protein-protein interaction data from ENYO easily discoverable to all, through the fantastic knowledge platform dedicated to human proteins that is neXtProt. We are happy to contribute to enabling their use by all researchers studying and interpreting protein networks in health and disease.